Evolus Inc Sustainability Reports
Evolus, Inc. operates as a medical aesthetics company focused on delivering advanced aesthetic procedures and products. The company primarily markets Jeuveau, an injectable neurotoxin formulation used for the temporary improvement in the appearance of moderate to severe wrinkles.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300VYQRYBQOT8V419
FIGI: BBG005CX4HL7
5 reports from 2017 to 2024
